Connect Biopharma Holdings Ltd - ADR

NASDAQ:CNTB  
1.18
-0.08 (-6.35%)
Earnings Announcements

Connect Biopharma Holdings Ltd Reports H1 2022 Loss Per Share $1.1

Published: 09/13/2022 21:42 GMT
Connect Biopharma Holdings Ltd - ADR (CNTB) - Connect Biopharma Holdings Ltd - H1 2022 Loss per Share $1.1 .
Connect Biopharma Reports First Half 2022 Financial Results and Provides Business Update.
Connect Biopharma Holdings Ltd - Believes It Has Sufficient Cash and Investments to Support Planned Operations Into at Least 2024.
Further Company Coverage: Cntbo ((reuters.
Briefs@thomsonreuters.
Com;)).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$3.58

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$3.22

More details on our Analysts Page.